79538-27-5 Usage
Uses
Used in Organic Synthesis:
(2,6-Difluoro-4-methoxyphenyl)methanol is used as a building block in organic synthesis for the creation of various chemical compounds. Its unique structure with fluorine and methoxy substitutions allows for the development of molecules with specific properties and reactivity.
Used in Pharmaceutical Applications:
In the pharmaceutical industry, (2,6-Difluoro-4-methoxyphenyl)methanol is used as a starting material or intermediate in the synthesis of new drugs and biologically active compounds. Its potential for creating novel therapeutic agents makes it a valuable component in drug discovery and development processes.
Used in Research and Development:
(2,6-Difluoro-4-methoxyphenyl)methanol is utilized in research settings to study its properties and explore its potential applications in various fields. This includes investigating its reactivity, stability, and interactions with other molecules, which can lead to the discovery of new uses and applications.
Check Digit Verification of cas no
The CAS Registry Mumber 79538-27-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 7,9,5,3 and 8 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 79538-27:
(7*7)+(6*9)+(5*5)+(4*3)+(3*8)+(2*2)+(1*7)=175
175 % 10 = 5
So 79538-27-5 is a valid CAS Registry Number.
79538-27-5Relevant academic research and scientific papers
PIPERIDINES OR PIPERIDONES SUBSTITUTED WITH UREA AND PHENYL
-
, (2019/10/01)
The present invention relates to a compound according to general formula (I) which acts as a modulator of FPR2 and can be used in the treatment and/or prophylaxis of disorders which are at least partially mediated by FPR2.
PHARMACEUTICAL COMPOSITION COMPRISING A PYRAZOLE-O-GLUCOSIDE DERIVATIVE
-
Page/Page column 47-48, (2008/12/07)
The invention relates toa pharmaceutical composition comprising a pyrazole-O-glucoside derivative selected from the group of compounds (1) to (29) according to claim 1 in combination with at least one second therapeutic agent which is suitable in the trea
METHODS FOR PREVENTING AND TREATING METABOLIC DISORDERS AND NEW PYRAZOLE-O-GLYCOSIDE DERIVATIVES
-
Page/Page column 34, (2010/11/25)
The invention relates to methods for preventing or treating metabolic disorders, for improving glycemic control, for preventing progression from impaired glucose tolerance, insulin resistance and/or from metabolic syndrome to type 2 diabetes mellitus, for
